3'-Phosphoadenosine
5'-phosphosulfate (PAPS) is the obligate cosubstrate and source of the sulfonate group in the sulfonation reactions catalyzed by both the cytosolic and membrane-associated sulfotransferases.
Sulfation is a high-affinity, lowcapacity conjugation system in xenobiotic metabolism partly because the levels of sulfation activity may be limited by PAPS availability.
Thus, the rate of PAPS synthesis may be an important factor in determining sulfation activity in tissues. A leveling out of the sulfation of drugs and xenobiotics may occur due to the limiting rate of PAYS synthesis, which may greatly affect their metabolism and biologic properties.
PAYS is synthesized from ATP and inorganic sulfate in a two-step reaction. Analyzing the regulation of the enzymes and cofactor levels involved in the synthesis of PAYS is important to our understanding of sulfation activities in cells and tissues. 3) structure and function of macromolecules, and 4) elimination of end products of catabolism. PAYS is the obligate cosubstrate that is synthesized in tissues to make available an "activated form" of sulfate for the sulfation reaction. PAYS participation in the reaction is dependent on its availability, which in turn is dependent on its synthesis, degradation, and ultimately its utilization in the sulfation reaction itself. PAYS synthesis is dependent on the availability of sulfate and on the activity of the two enzymes of its synthesis, ATP-sulfurylase and APS-kinase.
Although the kinetic properties of these two enzymes are well described, their in vivo regulation is not fully understood. Sulfation is a high-affinity, low-capacity enzymatic process in which the entire liver content of PAYS can be conswned in less than 2 mm. ATP-sulfurylase and AYSkinase can rapidly synthesize additional PAYS. The low capacity of sulfation in rats is due to the limited availabifity of sulfate, whereas in mice the sulfotransferases appear to limit sulfation capacity. Sulfation rates are not readily enhanced, but they can be decreased.
2,6-Dichloro- However, for some substrates sulfation can be an activation pathway. For instance, the sulfoconjugate of minoxidil is more active in producing desired hypotensive effects than is the parent chemical (1) . Also, the sulfate conjugate of Nhydroxy1-2-acetylaminofluorine (NOH-2-AAF) adducts to more protein and nucleic acids than does the parent compound, and is the major carcinogenic metabolite (2) . Sulfation also plays a role in 1) the inactivation of thyroid hormones, catecholamines, and steroid hormones,
2) the structure of sulfolipids, glycosamino-glycans, and glycoproteins, 3) the elimination of bile acids, and 4) the post-translational modification of tyrosine-containing secretory proteins.
THE SULFOCONJUGATION REACTION
Sulfation is the conjugation of a substrate with a sulfuryl group (-SO3-). This reaction occurs in the cytosol or is associated with the membranes of the Golgi apparatus of the cell. The cosubstrate 3'-phosphoadenosine 5'-phosphosulfate (PAYS)2 donates its sulfuryl group (-SOs) to a substrate (R-OH). The products are 3'-phosphoadenosine 5'-phosphate (PAY) and the sulfoconjugate (R-OSOI).
sulfotransferase
PAYS + R-OH -

PAY + R-0SO3
The sulfation reaction is catalyzed by a family of enzymes, the sulfotransferases (ST), whose individual family members were originally classified on the basis of their affinity and activity for substrates.
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The FASEB journal KLAASSEN AND BOLES low adenosine'-phosphosulfate (AYS) and PAYS concentrations. In rats, therefore, hepatic sulfation of AA is a high-affinity, low-capacity conjugation reaction, whereas glucuronidation is a low-affinity, high-capacity conjugation reaction (8).
Availability of PAYS as a limiting factor in sulfation
Sulfation of intravenously administered AA takes place predominantly in the liver (85); therefore, hepatic PAYS reflects cosubstrate availability for AA sulfation. In rats, the maximal capacity of AA sulfation occurs concomitantly with a decrease in hepatic PAYS levels (Fig. 2, Fig. 3) 
Tissue differences in sulfation capacity
The capacity-limited sulfation of AA in rats appears to be due to reduced availability of PAYS, which in turn is limited by the availability of its precursor, (Fig. 4) . At higher doses, however, glucuronidation tends to reach a maximal rate whereas sulfation increases in proportion to dose, or even greater than in proportion to dose. As a result, at the highest doses examined the rate of intestinal sulfation of harmol, a-naphthol, and AA approached or even exceeded the rate of glucuronidation. These studies point out the striking difference between systemic and intestinal conjugation.
In the intact rat, sulfation capacity is low and is saturable even at low doses. However, the glucuronidation pathway exhibits high maximal capacity, which is not reached even at high dosages.
In contrast, in the intestine the relative capacity for sulfation is higher than that for glucuronidation and does not exhibit saturation even at the high doses, whereas the capacity for glucuronidation is limited even at low doses. Therefore, the pattern of conjugation in the intact rat probably reflects conjugation in the liver, because AA perfused at a low dose into isolated rat liver is also preferentially sulfated (85).
Species differences in sulfation capacity
Not only are there differences in the sulfation capacity among tissues, there are species differences in the factors that account for limited sulfation capacity between rats and mice. As noted earlier, the availability of sulfate to form PAYS limits the hepatic sulfation of xenobiotics in the intact rat. In mice, the sulfation of AA is also capacity-limited; however, AA does not decrease hepatic PAYS concentrations as it does in rats (90, 91). Concomitantly, these rats eliminate AA from the tlood at a slower rate (Fig. 5) . In addition, AA-induced decreases in serum and liver sulfate concentrations are lower in rats on sulfate-and cysteinedeficient diets than in rats with a diet sufficient in sulfur (Fig. 6) (Fig. 7) and markedly decreases the sulfation of AA (Fig. 8) 
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